For insight into transcriptional mechanisms mediating physiological responses to GH, data mining was performed on a profile of GH-regulated genes induced or inhibited at different times in highly responsive 3T3-F442A adipocytes. Gene set enrichment analysis indicated that GH-regulated genes are enriched in pathways including phosphoinositide and insulin signaling and suggested that suppressor of cytokine signaling 2 (SOCS2) and phosphoinositide 3Ј kinase regulatory subunit p85␣ (Pik3r1) are important targets. Model-based Chinese restaurant clustering identified a group of genes highly regulated by GH at times consistent with its key physiological actions. This cluster included IGF-I, phosphoinositide 3Ј kinase p85␣, SOCS2, and cytokine-inducible SH2-containing protein. It also contains the most strongly repressed gene in the profile, B cell lymphoma 6 (Bcl6), a transcriptional repressor. Quantitative real-time PCR verified the strong decrease in Bcl6 mRNA after GH treatment and induction of the other genes in the cluster. Transcriptional network analysis of the genes implicated signal transducer and activator of transcription (Stat) 5 as hub regulating the most responsive genes, Igf1, Socs2, Cish, and Bcl6. Transcriptional activation analysis demonstrated that Bcl6 inhibits SOCS2-luciferase and blunts its stimulation by GH. Occupancy of endogenous Bcl6 on SOCS2 DNA decreased after GH treatment, whereas occupancy of Stat5 increased concomitantly. Thus, GH-mediated inhibition of Bcl6 expression may reverse the repression of SOCS2 and facilitate SOCS2 activation by GH. Together these analyses identify Bcl6 as a participant in GH-regulated gene expression and suggest an interplay between the repressor Bcl6 and the activator Stat5 in regulating genes, which contribute to GH responses. (Endocrinology 150: 3645-3654, 2009) S equencing of the human genome has provided new tools for addressing long-standing questions regarding transcription regulatory events. Whereas GH has long been recognized as a key regulator of growth and metabolism, new questions continually arise as to how it modulates cellular function. We have made considerable progress in understanding how GH signals through the GH receptor and its associated tyrosine kinase Janus kinase-2 (1, 2) and have achieved some knowledge of how GH regulates gene transcription, through analysis of well-studied GH target genes such as those encoding IGF1, C-fos, Spi2.1, Cyp2, and Cyp3 family members (3-10). However, to understand the diverse and complex events that are modulated by GH, it is informative to gain a global perspective of how GH regulates target genes and how they relate to physiological responses to GH.
For insight into transcriptional mechanisms mediating physiological responses to GH, data mining was performed on a profile of GH-regulated genes induced or inhibited at different times in highly responsive 3T3-F442A adipocytes. Gene set enrichment analysis indicated that GH-regulated genes are enriched in pathways including phosphoinositide and insulin signaling and suggested that suppressor of cytokine signaling 2 (SOCS2) and phosphoinositide 3Ј kinase regulatory subunit p85␣ (Pik3r1) are important targets. Model-based Chinese restaurant clustering identified a group of genes highly regulated by GH at times consistent with its key physiological actions. This cluster included IGF-I, phosphoinositide 3Ј kinase p85␣, SOCS2, and cytokine-inducible SH2-containing protein. It also contains the most strongly repressed gene in the profile, B cell lymphoma 6 (Bcl6), a transcriptional repressor. Quantitative real-time PCR verified the strong decrease in Bcl6 mRNA after GH treatment and induction of the other genes in the cluster. Transcriptional network analysis of the genes implicated signal transducer and activator of transcription (Stat) 5 as hub regulating the most responsive genes, Igf1, Socs2, Cish, and Bcl6. Transcriptional activation analysis demonstrated that Bcl6 inhibits SOCS2-luciferase and blunts its stimulation by GH. Occupancy of endogenous Bcl6 on SOCS2 DNA decreased after GH treatment, whereas occupancy of Stat5 increased concomitantly. Thus, GH-mediated inhibition of Bcl6 expression may reverse the repression of SOCS2 and facilitate SOCS2 activation by GH. Together these analyses identify Bcl6 as a participant in GH-regulated gene expression and suggest an interplay between the repressor Bcl6 and the activator Stat5 in regulating genes, which contribute to GH responses. (Endocrinology 150: 3645-3654, 2009) S equencing of the human genome has provided new tools for addressing long-standing questions regarding transcription regulatory events. Whereas GH has long been recognized as a key regulator of growth and metabolism, new questions continually arise as to how it modulates cellular function. We have made considerable progress in understanding how GH signals through the GH receptor and its associated tyrosine kinase Janus kinase-2 (1, 2) and have achieved some knowledge of how GH regulates gene transcription, through analysis of well-studied GH target genes such as those encoding IGF1, C-fos, Spi2.1, Cyp2, and Cyp3 family members (3) (4) (5) (6) (7) (8) (9) (10) . However, to understand the diverse and complex events that are modulated by GH, it is informative to gain a global perspective of how GH regulates target genes and how they relate to physiological responses to GH.
GH is a major promoter of postnatal longitudinal growth. In addition, GH antagonizes insulin action as part of the coordinated mechanisms by which multiple hormones maintain metabolic homeostasis. In conditions of chronic GH excess, devel-opment of insulin resistance and diabetes have long been recognized (11) (12) (13) . The signaling molecule phosphoinositide 3Ј kinase (PI3K) has been implicated in GH-induced insulin resistance (14, 15) , and the gene encoding its regulatory subunit p85 ␣ (PI3K p85␣) is induced by GH in adipocytes (15, 16) . Adipose tissue is one of the most sensitive target tissues for GH and plays a central role in its metabolic actions. In the present study, a profile of GH-regulated genes obtained using GH-treated adipocytes (16) was subjected to deep data mining to gain insight into genes involved in the physiological responses to GH. Through an integrative series of computational analyses, B celllymphoma 6 (Bcl6), a transcriptional repressor, was identified as a new participant in GH-regulated gene transcription. Functional studies support the role of Bcl6 in transcriptional repression of GH-regulated genes.
The gene profile used for analysis was obtained from microarray data sets from 3T3-F442A adipocytes treated with GH for 48 h, a time when GH induces insulin resistance, or for 4 h or 30 min for insight into triggering events. Genes were induced or inhibited by GH in time-dependent waves associated with biological processes regulated by GH. Expression of genes involved in transcription regulation was induced at 30 min, and expression of genes associated with lipid and cholesterol biosynthesis was inhibited at later times tested (48 h) (16) . The present analysis used the gene data sets to assess physiological pathways in which the GH-regulated genes are enriched and to identify key regulatory genes, with results pinpointing the genes for suppressor of cytokine signaling 2 (SOCS2) and PI3K p85a. Clustering using the model-based Chinese restaurant clustering (CRC) algorithm identified the same genes in a cluster of genes highly responsive to GH at 48 h; the cluster also included the gene for Bcl6, a transcriptional repressor, which was potently inhibited by GH. Transcriptional network analysis predicted relationships among the GH-regulated genes and showed expression of several of them, including Bcl6, to be linked to signal transducer and activator of transcription (Stat) 5, an established GH-regulated transcription factor. The computational predictions led to measurements suggesting inverse roles of Bcl6 and Stat5 in regulating the SOCS2 gene. Together these analyses identify the transcriptional repressor Bcl6 as a new transcriptional mediator in GH action and suggest that Bcl6 may play general roles in responses to GH and other regulators of metabolism and growth.
Materials and Methods

Computational analysis
This study analyzes a microarray data set with 561 probe sets showing significant differential expression signals in 3T3-F442A adipocytes treated with GH (500 ng/ml) for 30 min, 4 h, or 48 h (16) . Microarray data, based on U74A chip (Affymetrix, Santa Clara, CA), have been deposited in Gene Expression Omnibus (GSE2120). The data were submitted to the following computational analyses.
Gene set enrichment analysis (GSEA)
To identify pathways in which GH-regulated genes are enriched, GSEA (17) version 1.0 Java desktop application (http://www.broad.mit. edu/gsea/) was downloaded from Broad Institute of Massachusetts Institute of Technology and Harvard (Boston, MA). The analyses were performed separately on the microarray data at each of the three time points. The 175 gene sets used in the analysis were built from Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (18 -20) . Each gene set is comprised of all of the genes either in one murine KEGG pathway or in multiple murine KEGG pathways belonging to the same category documented by KEGG (http://www.genome.jp/kegg/pathway. html). For example, the cell growth and death category includes the pathways for cell cycle, apoptosis, and p53 signaling. The microarray data were normalized using robust multichip average (21) and then analyzed using GSEA, with the maximum gene set size of 500 and the minimum gene set size of 25; the other parameters were set as default. Outcomes were evaluated as normalized enrichment scores (NES).
Gene expression profile clustering
To examine patterns among highly regulated genes, the CRC algorithm 1.0 (22), a model-based algorithm capable of clustering genes displaying complex correlations (e.g. time shifted and/or inverted), was downloaded (http://www.sph.umich.edu/csg/qin/CRC). The CRC algorithm automatically infers the number of clusters and assigns cluster membership. CRC also ranks predicted clusters and their members. The settings for CRC clustering were selected to allow clustering of inverted, but not time-shifted correlations, due to the limited number of time points.
Transcriptional network analysis
To evaluate transcriptional relationships among genes highly responsive to GH, a transcriptional network was built using the GeneGo MetaCore database and tools for the cluster of genes (murine), which were strongly regulated by GH at 4 and 48 h (cluster D), except for interferoninducible p47 GTPase, which was not available in the GeneGo database.
Promoter analysis
Conserved transcription factor binding sites of interest were predicted by scanning the promoters of the genes in the cluster showing a similar pattern of responses to GH at 4 and 48 h (cluster D), using Genomatix tools. The orthologs for six species (Homo sapiens, Pan troglodytes, Macaca mulatta, Canis familiaris, Bos Taurus, Rattus norvegicus) of the analyzed mouse genes were retrieved from the Genomatix (Munich, Germany) genome annotation system ElDorado. The Genomatix optimized promoter length was used when available; otherwise a default region of Ϫ500 bp upstream of first transcription start site and ϩ100 bp downstream of last transcription start site was used. The promoter sequences of orthologs were aligned with Genomatix DiAlign and the binding sites were predicted with Genomatix MatInspector. The associated motif matrices of Stat5 and Bcl6 contained in Genomatix MatBase were used for query.
Physiological analyses
Gene expression
Murine 3T3-F442A adipocytes or preadipocytes were incubated with GH for various times. RNA was isolated and analyzed by quantitative real-time PCR as described previously (16) . Published primer sequences were used for Atf3, Gadd45␥, Gapdh (16); Socs2 (23); Cish, Bcl6 (24); KLF5 (25) , and Igf1 (26) . The primers for Pik3r1 were designed using Primer Express software (Applied Biosystems, Foster City, CA): 5Ј-CGTGGCACAGACTTGGTGTTT-3Ј (sense) and 5Ј-GGCAGT-GCTGGTGGATCC-3Ј (antisense). Data were normalized to glyceraldehyde-3-phosphate dehydrogenase, which was constant between experimental groups, and responses to GH are expressed either as (GHcontrol)/control, or as fold change, where control ϭ 1.
University of Alabama, Birmingham, AL) were analyzed by immunoblotting with anti-Bcl6 (C-19) (1:500; Santa Cruz Biotechnology, Santa Cruz, CA) as described (27) . Lysates from Ramos B cells [from R. Kwok (University of Michigan, Ann Arbor, MI) and W. Dunnick (University of Michigan, Ann Arbor, MI)] served as positive controls because they typically express Bcl6. The proteins were visualized using IRDye 800-coupled antirabbit IgG (1:12000; Rockland Immunochemicals, Gilbertsville, PA) on an Odyssey infrared scanning system (LI-COR Biosciences, Lincoln, NE). Molecular weight was estimated using protein molecular weight standards from Invitrogen (Carlsbad, CA).
Transcriptional activation
293T cells (28) were transfected by calcium phosphate coprecipitation with a SOCS2-luciferase (luc) plasmid in which the intronic GHresponsive sequence of human SOCS2 drives thymidine kinase-luc (29) , in the presence of the plasmids CMV-human Bcl6 (30) or pcDNA3. Cells were additionally transfected with plasmids for rat GH receptor (31) and RSV-␤-galactosidase for normalization. Eighteen hours later, cells were deprived of serum by replacing it with 1% BSA, incubated with human GH (500 ng/ml ϭ 22 nM; Eli Lilly, Indianapolis, IN)) for 24 -26 h and used to measure luciferase activity as described previously (32) . Data were analyzed by ANOVA with Bonferroni correction for multiple comparisons, using Prism (GraphPad, La Jolla, CA).
Chromatin Immunoprecipitation (ChIP)
3T3-F442A adipocytes or preadipocytes were treated with GH (500 ng/ml) for the indicated times. Lysates of cross-linked cells (input) were used for ChIP as described (33) using anti-Bcl6 (N-3), anti-Stat5 (C-17) (Santa Cruz), antiacetylated histone H4 (AcH4, Millipore, Billerica, MA), or normal rabbit IgG (Santa Cruz). The anti-Stat5 antibody used recognizes both Stat-5a and -5b. The term Stat5 is used herein to refer to both Stat5a and Stat5b, unless a distinction between them is pertinent. Primers targeting the binding site for Stat5 in murine SOCS2 were based on published sequences (29) . Quantification of the ChIP data were performed using Bio-Rad Multi-Analyst software (Hercules, CA).
Results
GSEA predicts GH-regulated pathways
For insight into mechanisms by which gene transcription mediates diverse responses to GH, a profile of genes regulated by GH was subjected to deep data mining. The profile identified 225 genes that were stimulated in time-dependent patterns after GH treatment in 3T3-F442A adipocytes as well as 287 genes that were repressed at the same times, as reported previously (16) .
GSEA was used to identify pathways that showed overall gene expression changes with GH treatment. GSEA discerns changes between two biological states in the expression levels of sets of genes selected a priori in transcriptional profiling experiments. This method has the advantage of evaluating the overall effect of a gene set rather than any single gene, a feature important to studies of complex physiological responses such as growth or metabolic regulation, in which small changes in a set of genes in a pathway might have a larger impact than a greater change in a single gene (17) . GSEA was performed on the entire microarray data set of GH-regulated genes in 3T3-F442A adipocytes. Because earlier analysis of the gene profile (16) revealed GH-regulated waves of gene transcription over time, the gene expression data for each time point were analyzed separately. The outcome yielded ranked gene sets at each time, evaluated through their NES, which indicate the extent that genes within the set are enriched in the study samples. Combining NES score rankings for each pathway at all time points indicated that the top five highly enriched gene sets regulated by GH include (in order) cell growth and death, insulin signaling, apoptosis, Janus kinase-Stat signaling and phosphoinositide signaling. These gene sets are consistent with reported biological processes and physiological functions regulated by GH (2, 12, 13, 35) . Another gene set that was relatively highly ranked was Toll-like receptor signaling; gene sets that were inhibited include pathways for tyrosine metabolism and glutathione metabolism. Because the original samples for microarray were obtained under conditions associated with GH-induced insulin resistance, the pathway for insulin signaling was examined further. Interestingly, within this pathway, the genes encoding SOCS2 and PI3K p85␣ were the most highly induced after GH treatment for 48 h.
Cluster analysis singles out Bcl6 as a novel gene inhibited by GH
The goal of clustering gene expression profiles is to group genes that display related expression patterns. Hierarchical clustering (36) of the data set of GH-regulated genes studied here had revealed clusters of genes sharing similar temporal patterns of response to GH (16) . In the present analysis, a recently developed, model-based clustering approach based on the CRC algorithm (22) was applied to cluster the genes regulated by GH (16) . CRC is able to recognize complex correlation patterns such as time-shifted and/or inverted patterns and group them into the same cluster and thus reveals functionally related genes not detected by most other clustering approaches. Inverted patterns are as important as positively correlated patterns because they show activities and regulatory functions of repressive transcription regulators.
Of the 12 clusters that were defined by CRC analysis (Fig. 1 , left panel), Cluster D was selected for initial analysis because it contains genes showing the greatest fold changes 4 -48 h after GH (Fig. 1, right panel) , consistent with delayed timing of GH responses such as longitudinal growth and insulin resistance (12, 13, 35) . The genes include well-studied GH target genes encoding IGF-I (3, 4, 37) and signaling molecules in the SOCS family, SOCS2 and CISH (29, 38) , as well as PI3K p85␣ (15) . Note that genes for SOCS2 and PI3K p85␣ were also highlighted in the GSEA pathway analysis. Additional genes stimulated by GH in this paradigm encode the transcription factors activating transcription factor (ATF)-3 and Kruppel-like factor (KLF)-5; signaling molecules repressor of G-protein signaling 16 and interferon-inducible p47 GTPase; the cytokine IL-6; and growth arrest and DNA damage inducible-45␥. These genes were induced by GH in adipocytes, and all except IL-6 showed highest levels of induction at 4 and 48 h. Importantly, one other gene in the cluster stood out as being the most highly repressed by GH: the gene encoding the transcriptional repressor Bcl6 was inhibited by GH by almost 75%.
The changes in expression of most of the genes in this cluster, including the dramatic decrease in Bcl6 expression, were confirmed by quantitative real-time PCR of RNA from GH-treated 3T3-F442A adipocytes (Fig. 2) . The overall changes in mRNA for each gene correspond with microarray findings at 4 or 48 h:
Expression of SOCS2 and CISH mRNA was the most highly stimulated by GH (50-to 60-fold). Bcl6 expression was inhibited almost 80%. These findings identify the gene encoding the transcriptional repressor Bcl6 as a novel target of GH and suggest that regulation of transcriptional repression plays a role in GHregulated gene expression.
Transcriptional network analysis highlights Stat 5-regulated genes, including the repressor Bcl6
For an unbiased view of transcriptional relationships among the GH-regulated genes in Cluster D, a transcriptional regulation network (Fig. 3) was built for genes in this cluster and their known interacting transcription factors, using the GeneGo database (St. Joseph, MO) with MetaCore software from GeneGo. The network relates the genes submitted with transcription factors that regulate them, as reported in the literature; for genes submitted that encode transcription factors, the target genes that they regulate are also linked. The analysis revealed links for regulation of seven of the genes in the cluster. Prominently, Stat5 emerged as a hub linking four of the genes: Stat5 has been shown to activate expression of the genes for SOCS2, CISH, and IGF-I (4, 29, 38) . Bcl6, the only gene in the cluster that was repressed by GH, was also linked to Stat5. Several reports have shown Stat5 to be a regulator of Bcl6 expression, either as an inducer or a repressor, depending on cell type (39 -41) . The coordination via Stat5 of these four genes, as revealed in the network, suggests that the genes may be coregulated by mechanisms involving Stat5 in response to GH. Genes for KLF5, ATF3, and IL-6 appear from the network analysis to be transcriptionally regulated by mechanisms not directly involving Stat5.
Because the genes in Cluster D had similar expression patterns in response to GH over time, it was speculated that they might be regulated by similar transcriptional mechanisms. The binding sites for five transcription factor families were searched in the promoter regions of genes in Cluster D (Table 1). Conserved sites for Stats and for Bcl6, as well as for CCAAT/enhancer binding protein (C/EBP), KLF/SP1, and ATF family factors, were predicted in almost every gene in the cluster. Stats and C/EBP family proteins are reported mediators of GH-regulated gene transcription (42, 43) ; ATFs, members of the cAMP response elementbinding protein family of transcription factors, are also regulated by GH (44, 45) . Bcl6 and KLFs/SP1 factors appear to be novel transcriptional regulators of the GH target genes containing these binding sites.
The transcriptional repressor Bcl6 mediates expression of GH target genes
The relationships between Bcl6 and Stat5 suggested by network and promoter analyses raise the possibility that these two transcription factors may be coordinated in regulating the expression of some of the other genes in this cluster. SOCS2 expression is not only highly stimulated by GH, but SOCS2 protein participates in GH signaling (46, 47) . When the most highly stimulated (SOCS2) and most highly repressed (Bcl6) genes in the present analysis were compared, the lowest GH concentrations (5 ng/ml) inhibited Bcl6 mRNA and induced SOCS2 expression, suggesting an inverse relationship that is highly responsive to GH (Fig. 4) . Consistent with this, in multiple experiments, inhibition of Bcl6 and induction of SOCS2 expression by GH followed a similar time course, with little or no responses at 30 min and substantial responses at 4 or 48 h, in both 3T3-F442A adipocytes and preadipocytes (supplemental Fig. 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http:// endo.endojournals.org) Furthermore, the endogenous Bcl6 protein was detectable in 3T3-F442A preadipocytes (Fig. 4, inset) ; Bcl6 was also detected in H4IIE rat hepatoma cells.
The inverse regulation of Bcl6 and SOCS2 by GH was evaluated further because SOCS2 is an established Stat5 target gene. The human SOCS2 gene contains a GH-inducible region in the first intron, which contains two GH-responsive Stat5 binding sites (29) . This sequence, fused upstream of thymidine kinase-luc (termed SOCS2-luc), was transfected into 293T cells along with DNA for GH receptor. Treatment with GH for 24 h stimulated SOCS2-luc as expected (Fig. 5A) . However, when Bcl6 was expressed, the activity of SOCS2-luc was strongly inhibited (Fig.  5A, white bars) , consistent with the role of Bcl6 as a transcrip- tional repressor. In the presence of Bcl6, GH failed to elicit a significant stimulation of SOCS2-luc over the repressed basal activity. Consistent with inverse regulation by GH, SOCS2-luc is inhibited by Bcl6, whereas Stat5 activates it, as expected (29) (data not shown).
Endogenous Bcl6 and Stat5 also show an inverse relationship in occupying endogenous SOCS2 DNA, as demonstrated by ChIP. Because SOCS2 is regulated by Bcl6 as well as Stat5, the occupancy of these two factors on the SOCS2 GH-responsive sequence was examined in vivo by CHIP (Fig. 5B) . Occupancy of endogenous Bcl6 on SOCS2 was evident in the absence of GH and decreased progressively after GH treatment; Bcl6 occupancy was almost undetectable 48 h after GH. For Stat5, occupancy on SOCS2 was negligible or absent without GH treatment (time 0), but Stat5 occupancy increased after GH. Thus, the occupancy of Bcl6 decreased as that of Stat5 increased (supplemental Fig. 2) . Occupancy of acetylated histone H4 is a positive control consistent with transcriptional activation of SOCS2; no occupancy was detected with IgG or beads alone. Together these findings indicate that endogenous Bcl6 occupies the SOCS2 gene in vivo. The occupancy of Bcl6 on DNA encompassing the GH-responsive sequence of SOCS2 decreases with GH treatment, whereas occupancy of Stat5 increases with GH. The inverse relationship between occupancy of Bcl6 and Stat5 on SOCS2 DNA is consistent with their respective abilities to repress and activate SOCS2.
Discussion
An integrative computational strategy reveals novel aspects of GH-regulated transcription
High throughput technologies such as DNA microarrays provide a global view of the expression patterns of all genes in the genome. This is important for analyzing complex biological processes such as those regulated by GH, including longitudinal growth or insulin resistance, in which it is crucial to understand how genes cooperate to carry out related series of reactions. Despite the fundamental advantages offered by high-throughput technologies, a key challenge is how to extract biological insights effectively from massive and noisy data. Powerful computational and statistical data mining tools have been developed and are able to translate the raw and noisy data into new scientific knowledge when applied appropriately. The computational tools used, when applied independently, provide pieces of evidence from different perspectives. Here an integrative computational data mining strategy was used; the combined approaches allow interpretation in the face of limitations inherent in each computational tool. This study demonstrates the effectiveness of a strategy using an array of computational tools to bring fresh insights and provide new clues for understanding complex biological processes regulated by hormones.
Through deep data mining, this study used several distinct computational approaches which reinforced each other to identify Bcl6 as a new player in GH-regulated transcription, and suggest its interplay with Stat5. GSEA focused on functionally important GH target genes, which facilitated identifying a cluster of interest. CRC clustering singled out Bcl6 because it identified Bcl6 among the genes most highly regulated by GH at 4 -48 h, despite the fact that Bcl6 was the one gene that was highly repressed, whereas other genes in the cluster were stimulated. Construction of a transcriptional network highlighted the role of Stat5 by linking Bcl6 with Stat5 as well as SOCS2 with Stat5, suggesting SOCS2 as a possible target gene of Bcl6. Promoter analysis predicted that some GH target genes contain both Stat5 and Bcl6 sites. Thus, the combination of high throughput technologies, integrative use of data mining tools, and statistical analysis, applied to questions in understanding GH transcription and its physiological actions have provided an efficient strategy to improve our understanding of mechanisms of transcriptional repression and their interface with transcriptional activation in the context of GH action.
The transcriptional repressor Bcl6 participates in GH-regulated transcription
This work implicates Bcl6 in GH-regulated transcription and demonstrates that Bcl6 serves as a potent repressor. The transcriptional repression properties of Bcl6 are well documented (48) , based on its established roles in immune function. Bcl6 is a member of the poxvirus and zinc finger/broad-complex, tramtrack and bric-a-brac zinc finger family of proteins. Translocations involving Bcl6 occur frequently in B cell lymphomas. Bcl6 is known for its essential role in B cell differentiation in germinal centers (48, 49) . Transcriptional repression by Bcl6 involves a variety of mechanisms: it recruits corepressors such as silencing mediator of retinoid and thyroid receptors (SMRT), nuclear receptor corepressor (NCoR), and Bcl6 interacting corepressor (BCoR) as well as histone deacetylases (50 -53) , and it associates with chromatin remodeling complexes and other repressors (54 -56) . A potent transcriptional repressor such as Bcl6 has not previously been implicated in GH-regulated transcription.
Previous investigation of gene repression by GH showed that Stat5 was modulated by other transcription regulatory molecules such as Forkhead box O1 (FoxO1), and hepatocyte nuclear factor (HNF)-3␤, -4␣, and -6 (9, 57-59). It remains to be determined whether Bcl6, and associated transcription regulatory factors, interact in complexes to regulate GH target genes. Because Bcl6 expression is dramatically inhibited by GH, the consequence of such reversal of repression likely contributes to activation of genes in response to GH. SOCS2 is an excellent candidate because Bcl6 occupies SOCS2 DNA within a GH-responsive sequence (29) , and its occupancy decreases on GH treatment. Furthermore, expression of Bcl6 inhibited SOCS2-luc under basal conditions; a small residual increase with GH was not statistically significant. Together these findings are consistent with SOCS2 being a new gene target of Bcl6. It can be speculated that in response to GH, Bcl6 functions in coordination with Stat5, which increases occupancy on SOCS2 DNA in a pattern reciprocal to the decrease in occupancy of Bcl6 after GH treatment. The consequence of both the increase in Stat5 and the decrease in Bcl6 is to increase expression of SOCS2 in response to GH. Thus, Bcl6 and Stat5 may participate in an inverse transcriptional repressor/activator relationship to facilitate expression of SOCS2 and perhaps other GH-regulated genes. It is relevant in this regard that the consensus DNA sequences that bind Bcl6 and Stat5 are remarkably similar (60, 61) . It is also recognized that reduced availability of Bcl6 protein through its degradation or inactivation may contribute to its reduced occupancy after GH; Erk-mediated phosphorylation and acetylation of Bcl6 have been reported to result in its degradation or inactivation (62, 63) . GH is known to induce phosphorylation via Erk 1/2 and acetylation to activate transcription factors such as C/EBP␤ (28, 32) and may similarly modulate other transcription regulatory proteins in the nucleus. Overall, Bcl6 appears to be a highly responsive new player in GH-regulated transcription.
Several studies have implicated Stats, particularly Stat5, in the regulation of Bcl6 gene expression. This regulation may be cell type specific because in a subset of germinal center cells, Stat5 increased expression of Bcl6 (41), whereas in B-lymphoma and other hematopoietic cell lines, Stat5 inhibited expression of Bcl6 (40) . Interestingly, Stat3 activation is coordinated with Bcl6 inhibition in regulating Blimp1 in plasma cell differentiation during B cell maturation (64) . Furthermore, prolactin, which activates Stat5, induces Bcl6 in pancreatic ␤-cells (39); Bcl6 in turn represses Menin expression, which allows the ␤-cell proliferation of adaptive islet growth, as in pregnancy or obesity (39) . However, a preliminary report indicates that prolactin inhibits Bcl6 expression in breast cancer cell lines (65) , suggesting that regulation of Bcl6 may vary with cell type. Further analysis of the role(s) of Bcl6 in repressing GH-regulated gene expression will provide new mechanistic insights into GH action.
Contributions of Bcl6 to physiological responses to GH
A novel observation in this study is that the transcriptional repressor Bcl6 is expressed and tightly regulated in adipocytes. Bcl6 is also detected in hepatoma cells, consistent with preliminary findings of Bcl6 mRNA in mouse liver (LaPensee, C., and J. Schwartz, unpublished data). , and plasmids for the GH receptor and ␤-galactosidase were transfected into 293T cells in the absence or presence of an expression plasmid for Bcl6. Cells were treated without (white bars) or with GH (black bars) for 24 h, and luciferase activity was measured, expressed as RLU (relative luciferase units). Bars, mean Ϯ SE for observations in six independent experiments. The expression of SOCS2-luc in the presence of Bcl6 was significantly (P Ͻ 0.01) less than in the absence of Bcl6 (compare white bars). The response to GH (compare white and black bars) was significant (P Ͻ 0.01) in the absence of Bcl6 but was not significant in the presence of Bcl6. SOCS2-luc in the presence of GH (compare black bars) in the absence of Bcl6 was significantly (P Ͻ 0.01) greater than in the presence of Bcl6. B, Bcl6 and Stat5 occupy SOCS2 inversely in response to GH: 3T3-F442A adipocytes or preadipocytes were treated with GH for the indicated times and nuclei were analyzed by ChIP, using antibodies against Bcl6, Stat5, or acetylated histone 4 (AcH4), with primers for the GH-responsive sequence in the SOCS2 gene. Samples treated with IgG or no antibody served as controls; 1% or 0.5% input is shown as indicated. IP, Immunoprecipitation. their metabolic status has not been described. In a gene profile of human muscle biopsy samples before and after euglycemic insulin clamp studies, the gene for Bcl6 was reported to be repressed by insulin (69) . A metabolic role of Bcl6 is further supported in this study by the observed coordination of the functions of Bcl6 with those of Stat5 in regulating SOCS2 because Stat5 has been amply demonstrated to participate in regulation of genes implicated in metabolic regulation and adipogenesis (70 -73) . In this regard, it is of note that the original microarray experiments that generated the gene profile analyzed in this study were performed using adipocytes under conditions in which GH can induce insulin resistance (16, 74) . The functions of many of the GH-regulated genes, identified by gene ontology categories, correspond with established physiological responses to GH (16) . GSEA identified insulin signaling pathway as one of the major pathways regulated by GH, implicating SOCS2 and PI3K p85␣. Suggestions that SOCS2 contributes to insulin resistance are also reported (34) . The present findings that Bcl6 is expressed in adipocytes and highly regulated by GH, which can induce insulin resistance, open new directions for analyzing mechanisms involving Bcl6 and transcriptional repression in regulation of metabolism in conditions such as obesity and diabetes.
FIG. 4.
Together, these studies demonstrate how systems biology approaches involving integrative computational strategies can lead to identification of Bcl6 as a new participant in GHregulated gene transcription, incorporating a potent and tightly regulated repressor as part of its regulatory mechanisms. Bcl6 is of additional interest because of its potential interplay with Stat5 in regulating target genes; such interactions may have broad relevance in metabolic and growth regulation and in the spectrum of cytokine actions that contribute to immune regulation and overall growth in normal and pathological conditions.
